Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00507702 · ClinicalTrials.gov registry record
Identification of Key Blood Molecular Markers for Immunotherapy
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 191
- Enrollment target
NCT00507702: Clinical Trial study, sponsored by Stanford University.
NCT00507702 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 191 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00507702 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 191 participants
- Enrollment target
Study Summary
To identify unique blood markers in cancer patients so that we can identify patients with evidence of pre-existing immunity who may be a responder to immunotherapy.
Interventions
- PROCEDURE phlebotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2006-07-06 |
| Est. Completion | 2015-02-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00507702
The ClinicalTrials.gov registry entry for NCT00507702 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 191 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which phlebotomy is the first listed.
NCT00507702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00507702 about?
NCT00507702 is a clinical study titled "Identification of Key Blood Molecular Markers for Immunotherapy". To identify unique blood markers in cancer patients so that we can identify patients with evidence of pre-existing immunity who may be a responder to immunotherapy.
What is the current status of trial NCT00507702?
This trial is currently terminated. The enrollment target is 191 participants. The study started on 2006-07-06. Estimated completion is 2015-02-25.
What interventions are being tested in trial NCT00507702?
The interventions under investigation include: phlebotomy (PROCEDURE).
Who is sponsoring clinical trial NCT00507702?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.